Neumora Therapeutics, Inc. Common StockNMRANASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank20
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P20
Within normal range
vs 2Y Ago
-0.9x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2024-40.00%
2023-38.51%
202242.75%
2021-148.46%
20200.00%
20190.00%